Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Long-Term Deferred Tax (2016 - 2025)

Dolby Laboratories (DLB) has disclosed Long-Term Deferred Tax for 17 consecutive years, with $214.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Deferred Tax fell 5.58% year-over-year to $214.3 million, compared with a TTM value of $214.3 million through Dec 2025, down 5.58%, and an annual FY2025 reading of $214.4 million, down 2.46% over the prior year.
  • Long-Term Deferred Tax was $214.3 million for Q4 2025 at Dolby Laboratories, roughly flat from $214.4 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $228.6 million in Q2 2025 and bottomed at $135.6 million in Q1 2021.
  • Average Long-Term Deferred Tax over 5 years is $195.7 million, with a median of $205.3 million recorded in 2023.
  • The sharpest move saw Long-Term Deferred Tax soared 39.5% in 2021, then dropped 5.58% in 2025.
  • Year by year, Long-Term Deferred Tax stood at $164.9 million in 2021, then rose by 16.54% to $192.2 million in 2022, then grew by 7.54% to $206.7 million in 2023, then increased by 9.85% to $227.0 million in 2024, then fell by 5.58% to $214.3 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for DLB at $214.3 million in Q4 2025, $214.4 million in Q3 2025, and $228.6 million in Q2 2025.